Jul. 11, 2024

JCR Affirmed AA+p on Astellas Pharma; Revised Outlook to Negative

May. 01, 2023

Astellas Pharma to Acquire a U.S. Company for Approx. USD 5.9 Billion - Finances Will Deteriorate, but Immediate Rating Revision Is Not Necessary

Sep. 07, 2022

JCR Affirmed AA+p/Stable Long-term Issuer Rating on Astellas Pharma

Jun. 15, 2022

Highlights of Major Pharmaceutical Companies' Financial Results for Fiscal Year Ended March 2022

Jun. 01, 2021

Highlights of Major Pharmaceutical Companies' Financial Results for Fiscal Year Ended March 2021

Oct. 23, 2020

JCR Affirmed AA+p/Stable Long-term Issuer Rating on Astellas Pharma

Jun. 17, 2020

Highlights of Major Pharmaceutical Companies' Financial Results for Fiscal Year Ended March 2020

Dec. 03, 2019

Astellas Pharma Acquires US Biotechnology Firm - Limited Impact on Rating

Sep. 11, 2019

JCR Affirmed AA+p/Stable Long-term Issuer Rating on Astellas Pharma

Jun. 25, 2019

Highlights of Major Pharmaceutical Companies' Financial Results for Fiscal Year Ended March 2019

Sep. 21, 2018

JCR Affirmed AA+p/Stable Long-term Issuer Rating on Astellas Pharma

Jul. 18, 2017

JCR Affirmed AA+p/Stable Long-term Issuer Rating on Astellas Pharma

Jul. 20, 2016

JCR Affirmed AA+p/Stable Long-term Issuer Rating on Astellas Pharma

Aug. 17, 2015

JCR Affirmed AA+p/Stable Long-term Issuer Rating on Astellas Pharma

Jul. 14, 2014

JCR Affirmed AA+p/Stable Long-term Issuer Rating on Astellas Pharma

Aug. 02, 2013

JCR Affirmed AA+p/Stable Long-term Issuer Rating on Astellas Pharma

Sep. 04, 2012

JCR Affirmed AA+p/Stable Long-term Issuer Rating of Astellas Pharma

Jul. 20, 2011

Affirmed AA+p/Stable rating on sr.debts of Astellas Pharma

Aug. 24, 2010

Affirmed AA+p/Stable on sr.debts of Astellas Pharma

Jun. 26, 2009

Affirmed AA+p/Stable on sr.debts of Astellas Pharma

Mar. 28, 2008

Affirmed AA+p/Stable on sr.debts of Astellas Pharma